Vineet Laboratories share price
NSE: VINEETLABBSE: 543298Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹37.19.
- Next results date: the board meets on 26 Oct 2026 to consider: financial results and other business matters.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹70 Cr3,234th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,53,94574.5% delivered
Results
Standalone; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Mar 2026Filed 26 Aug
- Revenue
- ₹19 Cr
- Net profit
- ₹1.22 Cr
Revenue by year
Net profit by year, a loss in red
- Net profit
- Loss
| ₹ crore | Jun 2024Filed 29 Aug | Sep 2024Filed 13 Nov | Dec 2024Filed 12 Feb | Mar 2025Filed 10 Jun | Jun 2025Filed 22 Jul | Sep 2025Filed 19 Dec | Dec 2025Filed 14 Feb | Mar 2026Filed 26 Aug |
|---|---|---|---|---|---|---|---|---|
| Revenue | 23.9 | 19.0 | 18.1 | 14.1 | 7.4 | 17.4 | 15.6 | 18.9 |
| Net profit | −2.1 | −1.8 | −5.7 | −10.5 | −0.9 | 0.4 | 0.9 | 1.2 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | −8.9% | −9.6% | −31.5% | −74.8% | −11.6% | 2.3% | 5.4% | – |
The quarters either side of a change of basis do not compare. From the quarter to Mar 2026, the company reports a discontinued business.
Business segments
In the year to Mar 2026 the company reports one business segment, Active pharmaceuticals ingredient and intermediates, which carries all its revenue.
Valuation
Today, against the company's own history. Not shown, P/E: no results for a period ending in the last six months, or nine for a company filing half-yearly. Not shown, P/B: no results for a period ending in the last six months, or nine for a company filing half-yearly. Not shown, EV/EBITDA: no results for a period ending in the last six months, or nine for a company filing half-yearly.PE ratio and valuation history
At or below today's level on 79% of 1,213 trading days over the last 5 years.
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −6.9% | – | – | 0.0% |
| 3 years | −11.1% | −15.0% | +4.5% | 0.0% |
Peers and competitors
Pharmaceuticals, 216 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Vineet Laboratories in market cap.
Vineet Laboratories is not on the chart: it has no P/E or return on equity today
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Cian HealthcareCHCL | 76 | – | 8.9 | – | −8.1% | – | −113.9% | – | 0.00% |
 Shelter PharmaSHELTER | 75 | 8.3 | 1.0 | – | +44.4% | +24.7% | 15.1% | – | 0.00% |
 Sunil HealthcareSUNLOC | 71 | 19.9 | 1.0 | 10.0 | −0.6% | +1,851.4% | 5.2% | 4.9% | 0.00% |
 Source Natural Foods & Herbal SupplSOURCENTRL | 70 | 18.6 | 2.7 | 11.9 | +63.1% | +20.6% | 15.6% | 16.7% | 0.00% |
 Zenith DrugsZENITHDRUG | 68 | 17.2 | 0.9 | – | +28.4% | −44.9% | 5.5% | – | 0.00% |
 Onyx BiotecONYX | 67 | – | 1.2 | – | +12.1% | −104.3% | −0.4% | – | 0.00% |
 PhaarmasiaPHRMASI | 62 | 3.5 | 2.8 | 28.6 | +111.8% | – | 114.5% | 7.1% | 0.00% |
 Rekvina LaboratoriesVINRKLB | 62 | – | – | – | – | – | – | −139.0% | 0.00% |
Dividends
Per share, by the year it was paid for, and the latest payments.Dividend history and dates
Dividend per share, ₹, restated for later splits and bonuses
Dividend per share. The dividends declared for the year, each restated to today's share count by the splits and bonuses after its own ex-date, added up.| Ex-date | Type | Per share |
|---|---|---|
| 19 Sep 2022 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹1.00 |
Latest announcements
Routine notices left out.Share news and announcements
Oct 2026
15 Oct · Management
Sep 2026
Vineet Laboratories share price by year
Each calendar year to 2025.Vineet Laboratories share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 36.78 | −37.8% | 60.22 | 27.01 |
| 2024 | 59.14 | −27.6% | 82.05 | 47.45 |
| 2023 | 81.65 | +29.1% | 81.65 | 40.20 |
| 2022 | 63.25 | −22.9% | 82.25 | 47.65 |
| 2021 | 82.05 | – | 119.40 | 46.20 |
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on NSE.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 23 Oct 2026 | 38.40 | 38.40 | 34.38 | 36.23 | 37.02 | 1,53,945 | 74.5% |
| 22 Oct 2026 | 38.99 | 39.00 | 36.71 | 37.19 | 38.14 | 56,953 | 80.7% |
| 21 Oct 2026 | 39.10 | 39.10 | 37.80 | 38.02 | 38.11 | 97,030 | 50.3% |
| 19 Oct 2026 | 39.60 | 39.60 | 38.25 | 38.70 | 38.60 | 54,823 | 65.6% |
| 16 Oct 2026 | 39.70 | 39.70 | 38.47 | 39.01 | 39.16 | 4,37,136 | 84.6% |
| 15 Oct 2026 | 41.00 | 41.30 | 38.00 | 38.58 | 38.87 | 80,754 | 62.1% |
| 14 Oct 2026 | 38.49 | 39.47 | 38.35 | 38.59 | 38.83 | 1,03,266 | 58.6% |
| 13 Oct 2026 | 38.00 | 38.59 | 36.71 | 37.93 | 37.92 | 1,19,171 | 74.2% |
| 12 Oct 2026 | 38.00 | 38.00 | 35.41 | 37.30 | 36.97 | 86,868 | 67.0% |
| 9 Oct 2026 | 37.90 | 37.90 | 34.61 | 37.45 | 36.47 | 54,462 | 59.9% |
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Rights issue history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 23 Dec 2025 | Rights issue | – | Shareholders were offered new shares. Noted, not adjusted for. |
Company details
- Legal name
- Vineet Laboratories Limited
- NSE symbol
- VINEETLAB
- BSE code
- 543298
- ISIN
- INE505Y01010
- Industry
- Pharmaceuticals & Biotechnology
- Listed
- Jun 2021
- Face value
- ₹10
- CIN
- L24304TG2016PLC112888
- Corporate identity number, the registrar of companies' code for it